KALV Forecast and Technical Stock Analysis
Sell candidate since 2019-08-14 Gain 1.36%
KalVista Pharmaceuticals Inc gained 1.61% in the last trading day ( Friday, 16th Aug 2019 ), rising from $16.11 to $16.37 During the day the stock fluctuated 4.02% from a day low at $15.91 to a day high of $16.55. The price has fallen in 5 of the last 10 days , but is still up by 0.99% over the past 2 weeks. Volume fell in the last day by -9 525 shares and in total, 50 226 shares bought and sold for approximately $822 200.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the KALV stock price was $18.89 and low was $15.03.
- 90 day high was $24.35 and low was $15.03.
- 52 week high for KalVista Pharmaceuticals Inc - $34.92 and low - $12.74.
KalVista Pharmaceuticals Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -29.65% during the next 3 months and, with 90% probability hold a price between $8.98 and $12.70 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday August 15, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. KalVista Pharmaceuticals Inc holds a buy signal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $17.45. On a fall, the stock will find some support from the short-term average at $16.06. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 45 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
KalVista Pharmaceuticals Inc finds support from accumulated volume at $16.34.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.64 between high and low, or 4.02%. For the last week the stock has had a daily average volatility of 6.35%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
6.35 %Average volatility
Very Low Low Medium High Very High
|KALV $16.37 ($0.26 1.61%)|
KALV is up $0.26 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for KALV based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the KALV analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!